Alzheimers Research on SARRP Leads to Phase 1 Clinical Study

 In Life Sciences News

In this study, Low Dose Brain Irradiation Reduces
Amyloid-ß and Tau in 3xTg-AD Mice,
the researchers used the SARRP to deliver hemi-brain irradiations with a 2-beam treatment plan. The variable collimator made it possible to adjust the treatment beam size to each mouse. The preclinical results have led to a phase 1 clinical study.

See more from Dr. Wilson’s and the rest of the team’s research below, and find the full article here.

Please fill out your details below to download our brochures. Your only need to do once to unlock access.